×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
Download -
· Vasi hea documentului ,XALKORI (crizotinib) 200mg si 250 mg capsule pentru administrare orala.lncluderea unei noi atentionari referitoare la insuficienta
Download
Transcript
Page 1
Page 2
Page 3
Page 4
Page 5
LOAD MORE
Top Related
Xalkori : EPAR - Public assessment report - European Medicines
Effet du crizotinib sur la survie
Non-Interventional Study Protocol A8081031 Xalkori
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS...Table 1. XALKORI dose modification – haematological toxicitiesa,b CTCAEc Grade XALKORI treatment Grade 3 Withhold until recovery to Grade
PathoBasic Molekularpathologie Teil 1 · Vemurafenib (Zelboraf) B-Raf Melanoma Crizotinib (Xalkori) EML4/ALK, Met NSCLC Vandetanib (Caprelsa) EGFR, VEGFR, Ret TyroidCa mTor-Hemmer
ATENTIONARI SI CONTRAINDICATII in Folosirea Remediilor Naturiste
Crizotinib (Xalkori™„錄2-討論案2... · Treated brain metastases allowed N=318 IV, day 1, 21-day cycle (n=159) outcomes (EORTC QLQ-C30, LC13) Shaw et al NEJM 2013 CROSSOVER
Leading In Biopharmaceutical Innovation...cell lung cancer (NSCLC). These data established Xalkori as a standard of care for this patient population. Xalkori also has received conditional